VALLE FRANCO (Senior Vice President, Finance) sold 3.25K shares of EIDOS THERAPEUTICS, INC. on the open market
Open‑market sale worth $407.6K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/13/2021ACC: 0000899243-21-001847
Officer· Senior Vice President, Finance
Since Jan 2020
-3.25K
Net shares
Net seller
$407.6K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
3.25K acquired · 6.49K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+1.50K
Price / share
$7.24
Trade value
$10.86K
% of position
New position
1/11/2021
0.00→1.50K
Common Stock
Direct
Shares
−1.50K
Price / share
$125.61
Trade value
$188.41K
% of position
New position
1/11/2021
1.50K→0.00
Common Stock
Direct
Shares
+1.75K
Price / share
$7.24
Trade value
$12.65K
% of position
New position
1/12/2021
0.00→1.75K
Common Stock
Direct
Shares
−1.75K
Price / share
$125.44
Trade value
$219.15K
% of position
New position
1/12/2021
1.75K→0.00
Total
Net shares
+0.00
Net value
-$384.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/11/2021 | M · Option Exercise | +1.50K | $7.24 | $10.86K | New position | 0.00 | 1.50K |
| Common Stock Direct | 1/11/2021 | S · Sale | −1.50K | $125.61 | $188.41K | New position | 1.50K | 0.00 |
| Common Stock Direct | 1/12/2021 | M · Option Exercise | +1.75K | $7.24 | $12.65K | New position | 0.00 | 1.75K |
| Common Stock Direct | 1/12/2021 | S · Sale | −1.75K | $125.44 | $219.15K | New position | 1.75K | 0.00 |
| Total | +0.00 | -$384.05K | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.50K shares
Shares
−1.50K
Strike price
7.24
Held after
26.10K
Exercisable
—
1/11/2021
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.75K shares
Shares
−1.75K
Strike price
7.24
Held after
24.35K
Exercisable
—
1/12/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.50K shares | 1/11/2021 | M · Option Exercise | −1.50K | 7.24 | — | 26.10K |
| Stock Option (Right to Buy) Direct | Common Stock1.75K shares | 1/12/2021 | M · Option Exercise | −1.75K | 7.24 | — | 24.35K |